Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L K Chan

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 1, 1996
p53 mutational spectrum of esophageal carcinomas from five different geographical locales in ChinaM L Lung, W C Chan, Y S Zong, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|December 3, 2002
Prone table stereotactic breast biopsyJ Y H Hui, L K Chan, R L M Chan, et al.
Frontiers in Psychology|July 18, 2022
Evaluating the Effectiveness of Digital Content Marketing Under Mixed Reality Training Platform on the Online Purchase IntentionC H Li, O L K Chan, Y T Chow, et al.
Pigment Cell & Melanoma Research|April 12, 2011
Constitutive Smad linker phosphorylation in melanoma: a mechanism of resistance to transforming growth factor-β-mediated growth inhibitionKarine A Cohen-Solal, Kim T Merrigan, Joseph L-K Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2011
Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapiesHwa Jin Lee, Brian A Wall, Janet Wangari-Talbot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2009
A phase 0 trial of riluzole in patients with resectable stage III and IV melanomaDana Yip, Maithao N Le, Joseph L-K Chan, et al.
Translational Oncology|March 10, 2015
Targeting Glutamatergic Signaling and the PI3 Kinase Pathway to Halt Melanoma ProgressionStephen A Rosenberg, Scot A Niglio, Negar Salehomoum, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
Antiangiogenic agents are effective inhibitors of endometriosisM Louise Hull, D Stephen Charnock-Jones, Clement L K Chan, et al.
Oncogene|October 10, 2012
Krüppel-like factor 4 (KLF4) suppresses neuroblastoma cell growth and determines non-tumorigenic lineage differentiationC K Y Shum, S T Lau, L L S Tsoi, et al.
Oral Oncology|April 25, 2012
The strength/weakness of the AJCC/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvementAnne W M Lee, W T Ng, L K Chan, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 1, 1996
p53 mutational spectrum of esophageal carcinomas from five different geographical locales in ChinaM L Lung, W C Chan, Y S Zong, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|December 3, 2002
Prone table stereotactic breast biopsyJ Y H Hui, L K Chan, R L M Chan, et al.
Frontiers in Psychology|July 18, 2022
Evaluating the Effectiveness of Digital Content Marketing Under Mixed Reality Training Platform on the Online Purchase IntentionC H Li, O L K Chan, Y T Chow, et al.
Pigment Cell & Melanoma Research|April 12, 2011
Constitutive Smad linker phosphorylation in melanoma: a mechanism of resistance to transforming growth factor-β-mediated growth inhibitionKarine A Cohen-Solal, Kim T Merrigan, Joseph L-K Chan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2011
Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapiesHwa Jin Lee, Brian A Wall, Janet Wangari-Talbot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2009
A phase 0 trial of riluzole in patients with resectable stage III and IV melanomaDana Yip, Maithao N Le, Joseph L-K Chan, et al.
Translational Oncology|March 10, 2015
Targeting Glutamatergic Signaling and the PI3 Kinase Pathway to Halt Melanoma ProgressionStephen A Rosenberg, Scot A Niglio, Negar Salehomoum, et al.
The Journal of Clinical Endocrinology and Metabolism|June 6, 2003
Antiangiogenic agents are effective inhibitors of endometriosisM Louise Hull, D Stephen Charnock-Jones, Clement L K Chan, et al.
Oncogene|October 10, 2012
Krüppel-like factor 4 (KLF4) suppresses neuroblastoma cell growth and determines non-tumorigenic lineage differentiationC K Y Shum, S T Lau, L L S Tsoi, et al.
Oral Oncology|April 25, 2012
The strength/weakness of the AJCC/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvementAnne W M Lee, W T Ng, L K Chan, et al.
Pageof 8